Retatrutide

Triple Agonist · GLP-1 + GIP + Glucagon

Retatrutide is a scientific revolution without precedent — the first tri-agonist ever developed. What makes it category-defining is the Glucagon receptor activation: it mimics a prolonged fasting state, ramping up resting energy expenditure and forcing the body to burn accumulated fat continuously. Multiple clinical trials demonstrate up to 24% total body-weight loss in advanced phases, surpassing every previous medical record.

• Unprecedented fat mobilization — attacks visceral and stubborn adipose tissue at extreme speed, far surpassing any single- or dual-agonist compound
• Near-total fatty liver reversal — clinical results show dramatic reduction of hepatic fat accumulation, restoring liver health in affected patients
• Insulin resistance repair — reprograms the body to process carbohydrates with ultra-efficiency, preventing type-2 diabetes development
• Hedonic hunger elimination — completely silences the mental noise around food, killing obsessive cravings for sugar, ultra-processed food and stress-driven binge eating
• Complete metabolic flexibility — the triple mechanism ensures the body burns fat, optimizes glucose and increases resting energy expenditure simultaneously